Keeping you informed with the latest company updates and investment insights from renowned stock market professionals:

Company Q&A – Hear directly from company management as they discuss the latest updates and strategic developments.

Small-Cap Investing – UK equity analyst and market commentator Paul Scott joins Paul Hill to discuss their latest views on a range of stocks.

 

 

KEFI Gold & Copper: Could a district-scale play now emerge around Tulu Kapi?

YouTube video thumbnail

KEFI's  annual report and accounts have been released for the year to December 2025, and the company's chairman, Harry Anagnostaras-Adams has taken the opportunity to update investors on progress at the Tulu Kapi project as well as in Saudi Arabia. The construction process is now well underway at Tulu Kapi, and the low projected cost per ounce means that annual EBITDA could run anywhere in the range of US$355 million up to nearly US$700 million. While construction is going on, though, serious exploration will once again resume, as the company attempts to prove that Tulu Kapi isn't just a one-off, but is in fact the first in a district-scale play.

 

Pinnacle Silver & Gold: Gold recoveries better than 97% at El Potrero

YouTube video thumbnail

A second round of metallurgical testwork at Pinnacle Silver & Gold's  El Potrero project in Mexico has demonstrated that gold recoveries across the three main veins are likely to run higher than 97%. Meanwhile, underground drilling at El Potrero continues, part of an 108-hole programme. Pinnacle's chief executive Bob Archer joins Vox to provide more details

 

Will Great Western Mining's OTC listing boost liquidity?

YouTube video thumbnail

Great Western Mining  is gearing up for a major drilling campaign on its Nevada tungsten properties, due to commence shortly. In the meantime, though, the company has listed its shares on the OTC in the USA in a bid to attract interest from US investors. The thinking is that at a time of increasing anxiety about supplies of critical minerals, like tungsten, US investors will favour a US-based project. Great Western's Brian Hall joins Vox to tell us more

 

Mindflair benefits as a key investment, CameraMatics secures €48m growth investment

YouTube video thumbnail

Mindflair plc (AIM: MFAI)  has just benefited from its sixth SVV1 portfolio realisation. CameraMatics, the AI-powered fleet intelligence platform, has completed a €48m growth round led by Blume Equity, alongside the Irish Strategic Investment Fund and Goodbody Capital Partners. In conversation with Vox Markets, Director Nicholas Lee explains what the deal means for shareholders and why Mindflair is now debt-free.

 

ECR fine-tunes gold production process at Raglan

YouTube video thumbnail

ECR Minerals  is up and running and producing gold at its Raglan project in Australia. The company has been busy fine-tuning operations there in the past few weeks, shooting a Lidar survey and consulting an expert in alluvial projects for ideas on making further efficiencies. Meanwhile, the company is also moving closer to production at the much larger Maddens project, where grades have run as high as 25 grams per tonne in the past. ECR's executive chairman Nick Tulloch joins Vox to tell us more

 

Finseta Interview - Last week’s positive FY’25 results and ‘in line’ outlook

YouTube video thumbnail

In this upbeat interview, CEO James Hickman and CFO Andrew Richards of Finseta  – a specialist B2B payments and foreign exchange platform - take me through last week’s positive FY’25 results and ‘in line’ outlook. 

 

Poolbeg Pharma - POLB 001 Trial Activated as CRS Prevention Study Moves Into Patients

YouTube video thumbnail

Poolbeg Pharma  has announced the activation of the first clinical trial site for its POLB 001 TOPICAL study, marking a key operational milestone for its lead programme. The trial will evaluate POLB 001 as a potential preventative treatment for Cytokine Release Syndrome in relapsed/refractory multiple myeloma patients receiving teclistamab, an approved bispecific antibody. With recruitment now underway and interim data expected in summer 2026, the study could provide an important early readout on POLB 001’s role in improving the safety and accessibility of cancer immunotherapies.

 

 

2 P’s on a Pod: Small Cap Investing with Paul Hill & Paul Scott

YouTube video thumbnail

In this week’s live smallcap show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 19 stock ideas.